Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Short Stature Born Small for Gestational Age (SGA)
Interventions
DRUG

Genotropin (somatropin)

Genotropin(somatoropin) 12 mg, Genotropin(somatropin) will be given at a dose of 0.067 mg/kg/day or 0.033 mg/kg/day to all participating patients

Trial Locations (19)

807-8555

University of Occupational and Environmental Health Hospital, Kitakyushu

371-8511

Gunma University Hospital, Maebashi

730-8518

Hiroshima City Hospital, Hiroshima

078-8510

Asahikawa Medical University Hospital, Asahikawa

080-0805

Hokkaido Social Service Association Obihiro Hospital, Obihiro

060-8648

Hokkaido University Hospital, Sapporo

020-8505

Iwate Medical University Hospital, Morioka

252-0375

Kitasato University Hospital, Sagamihara

860-8556

Kumamoto University Hospital, Kumamoto

606-8507

Kyoto University Hospital, Kyoto

980-8574

Tohoku University Hospital, Sendai

700-8558

Okayama University Hospital, Okayama

594-1101

Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi

553-0003

Osaka Employees' Pension Hospital, Osaka

430-8558

Seirei Hamamatsu General Hospital, Hamamatsu

105-8470

Federal Officers' Mutual Aid Association Toranomon Hospital, Minato-ku

157-8535

National Center for Child Health and Development, Setagaya-ku

683-8504

Tottori University Hospital, Yonago

409-3898

Yamanashi University Hospital, Chūō

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY